Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Department expert qualified; panel hears opening statements in APRN Sheehan disciplinary hearing

Department of Public Health - Practitioner Licensing and Investigation Section · February 19, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

A Department of Public Health licensing panel qualified Dr. Jill Espelen as the department's psychiatric expert and heard opening statements in a disciplinary case alleging that APRN Sheehan prescribed antipsychotic medications without adequate coordination, documentation or monitoring while the patient was at Gladeview Health Center.

A three‑member Department of Public Health licensing panel qualified Dr. Jill Espelen on June 13, 2024, as the department's expert in a disciplinary proceeding alleging failures in prescribing and monitoring psychotropic medication for "patient number 1" at Gladeview Health Center.

The Department opened the hearing with a summary that the patient was admitted to Gladeview on or about Dec. 3, 2021, and discharged about Jan. 12, 2022. Department counsel said the department's theory is that APRN Sheehan prescribed antipsychotic medications without adequately discussing them with the patient's authorized health‑care representative, failed to consult other treating providers, did not document the risks and benefits of the drugs prescribed, and did not monitor the patient sufficiently for side effects. The department called Dr. Espelen, a board‑certified…

Already have an account? Log in

Subscribe to keep reading

Unlock the rest of this article — and every article on Citizen Portal.

  • Unlimited articles
  • AI-powered breakdowns of topics, speakers, decisions, and budgets
  • Instant alerts when your location has a new meeting
  • Follow topics and more locations
  • 1,000 AI Insights / month, plus AI Chat
30-day money-back on paid plans